Skip to main content
logo
HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
494.99
-12.49 (-2.46%)
At close: Nov 6, 2026, 4:00 PM EST
500.00
+5.01 (1.01%)
After-hours: Nov 6, 2026, 7:57 PM EST

HCA Healthcare Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Capitalization
103,40092,39086,493105,802106,53599,72892,16485,07676,027104,88984,14888,21872,45066,90483,48473,10667,84152,75249,65975,69279,908
Market Cap Growth (YoY)
-4.24%-7.36%-6.15%24.36%40.13%-4.92%9.53%-3.56%4.94%56.78%0.80%20.67%6.79%26.83%68.11%-3.42%-15.10%-32.11%-27.36%19.28%43.59%
Enterprise Value
154,807146,245138,599156,612154,969148,208140,514131,346120,901149,684127,757131,889115,412109,445125,845115,000108,78395,01689,118113,294115,349
Last Close Price
494.99426.74389.17471.42464.38423.30379.82341.92296.33400.41315.99327.41265.17240.42295.94256.59232.94178.00162.33241.32246.87

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
16.3813.6412.6515.5715.7015.7215.4414.7213.2017.6914.6716.1313.8211.7114.4712.7512.029.817.6311.1211.49
Forward PE
16.1613.9412.6215.6115.9015.5414.6913.8712.6017.1215.0016.1914.2512.7616.6515.3313.4510.199.6013.3214.11
PS Ratio
1.311.171.111.391.411.341.271.191.081.511.231.321.121.061.351.201.130.880.831.271.36
PB Ratio
--20.09-26.95-35.53-38.45-46.19-74.45-194.24136.99133.4562.8469.4668.35187.41181.09315.11-929.32-67.81-43.48182.8353.67
P/FCF Ratio
17.3115.4714.4213.3513.8512.3212.6417.1913.4817.8417.2216.2415.4615.2916.9217.2116.4412.6413.5216.7014.85
P/OCF Ratio
9.268.277.788.148.437.777.728.777.239.878.778.747.687.218.508.147.966.256.459.108.92
PEG Ratio
1.751.481.261.411.221.221.231.131.011.371.571.711.671.331.751.831.781.521.271.231.04

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
1.971.861.782.052.051.991.931.841.712.151.871.981.781.732.031.891.811.591.481.901.96
EV/EBITDA Ratio
9.809.268.8010.0610.019.819.699.248.7210.899.5710.259.098.9110.239.379.057.947.269.119.21
EV/EBIT Ratio
12.8412.1311.4813.0812.9512.7412.6812.1211.4614.2512.5513.5211.9911.8513.5512.3812.0210.539.5311.8711.92
EV/FCF Ratio
25.9224.4823.1119.7620.1518.3119.2726.5521.4425.4626.1424.2824.6225.0125.5127.0726.3622.7624.2625.0021.43

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
-11.40-11.40-16.07-16.74-17.57-21.47-37.45-106.0281.5157.1131.9533.1539.49115.1988.37174.88-550.68-50.73-35.6495.3824.67
Debt / EBITDA Ratio
3.123.153.023.082.802.822.832.922.853.212.822.922.733.313.082.952.953.143.103.102.73
Debt / FCF Ratio
8.788.788.606.296.335.736.369.398.027.638.757.758.939.408.269.559.749.4611.088.716.83
Net Debt / Equity Ratio
-11.18-11.18-15.71-16.38-17.16-20.96-36.61-103.3577.8753.3231.2632.0738.53112.4086.28170.84-536.99-49.29-34.7989.4023.63
Net Debt / EBITDA Ratio
3.263.263.203.133.073.003.133.183.123.053.133.173.223.273.233.233.263.203.242.982.81
Net Debt / FCF Ratio
8.618.618.416.156.185.596.229.157.667.138.567.508.719.178.069.339.509.1910.828.176.54
Asset Turnover
1.281.281.271.261.261.251.241.231.221.221.231.221.201.191.181.161.171.181.211.201.20
Inventory Turnover
26.4727.3826.7526.7326.7925.2924.5024.3724.3823.5322.2921.1620.0519.5618.8718.3118.6118.2017.9818.5718.80
Quick Ratio
0.630.630.780.640.740.640.720.900.850.870.780.870.870.820.840.871.000.991.071.051.01
Current Ratio
0.820.820.990.830.970.850.981.191.081.121.061.161.181.151.201.231.381.381.551.431.41
Return on Equity (ROE)
------13631.68%1605.77%824.40%1195.45%736.11%845.54%1234.24%--2139.94%965.25%1183.00%2259.57%525.28%352.48%
Return on Assets (ROA)
12.23%12.23%12.29%12.34%12.44%12.20%11.84%11.61%11.39%11.51%11.47%11.12%11.07%10.89%11.04%11.06%10.97%11.17%11.72%11.99%12.31%
Return on Invested Capital (ROIC)
21.36%22.37%21.45%21.63%21.49%21.63%20.02%19.11%19.23%19.74%19.11%18.83%18.02%17.81%17.80%19.09%18.18%18.62%19.00%21.00%21.51%
Return on Capital Employed (ROCE)
27.60%27.60%26.30%28.40%27.00%27.80%25.40%23.50%23.80%23.60%23.60%22.30%22.10%21.90%22.10%22.30%21.30%21.60%22.00%22.90%23.50%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
6.11%7.33%7.91%6.42%6.37%6.36%6.48%6.79%7.58%5.65%6.82%6.20%7.23%8.54%6.91%7.84%8.32%10.19%13.11%8.99%8.71%
FCF Yield
5.78%6.46%6.93%7.49%7.22%8.12%7.91%5.82%7.42%5.61%5.81%6.16%6.47%6.54%5.91%5.81%6.08%7.91%7.40%5.99%6.73%
Dividend Yield
0.63%0.70%0.76%0.62%0.61%0.65%0.71%0.77%0.87%0.63%0.78%0.73%0.88%0.95%0.76%0.86%0.92%1.16%1.20%0.79%0.73%
Payout Ratio
10.32%10.45%10.06%11.30%8.63%10.10%10.35%11.18%11.47%13.31%11.70%11.63%9.96%15.01%13.75%12.84%7.50%14.11%13.85%13.90%8.16%
Buyback Yield / Dilution
8.70%8.03%7.89%9.14%9.63%9.13%8.39%6.93%5.85%5.63%5.08%4.61%5.07%4.98%6.03%8.59%9.43%10.55%10.99%10.47%8.67%
Total Shareholder Return
9.33%8.73%8.64%9.75%10.24%9.78%9.10%7.70%6.72%6.26%5.85%5.34%5.95%5.93%6.79%9.45%10.35%11.71%12.19%11.26%9.41%
SEC Filings: 10-K · 10-Q